PA
TMUS icon

PharVision Advisers’s T-Mobile US TMUS Stock Holding History

PharVision Advisers’s Portfolio TMUS Stock Details TMUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,265
Closed -$257K – 599
2025
Q4 		$257K Buy
+1,265
New +$268K 0.13% 378
2025
Q3 		– Sell
-1,122
Closed -$267K – 796
2025
Q2 		$267K Buy
+1,122
New +$274K 0.38% 107

Other funds holding TMUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

PharVision Advisers's TMUS Position: Q1 2026 in Review

PharVision Advisers sold out of T-Mobile US (TMUS) in Q1 2026, closing a stake of 1,265 shares — an estimated $257K sold.

PharVision Advisers first reported a position in TMUS in Q2 2025 and held it in 2 quarters. The position peaked at $267K in Q2 2025. 1,719 funds tracked by Wall St. Rank hold TMUS as of Q1 2026.

  • PharVision Advisers reported no remaining T-Mobile US position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,265 T-Mobile US shares in Q1 2026, an estimated $257K.
  • PharVision Advisers first reported a position in T-Mobile US in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's T-Mobile US position peaked at $267K in Q2 2025.
  • 1,719 funds tracked by Wall St. Rank held T-Mobile US as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.